International Randomized Comparison Between DES Limus Carbostent and Taxus Drug-Eluting Stents in the Treatment of De Novo Coronary Lesions - NEXT

Description:

It is currently believed that the polymer coating in currently available drug-eluting stents (DES) predisposes to an increased risk of stent thrombosis. This has evoked interest in the incorporation of biodegradable polymers and polymer-free stent platforms in the next generation of DES. The current trial sought to compare intermediate outcomes with the use of a polymer-free DES compared with paclitaxel-eluting stents (PES) in patients with coronary artery disease undergoing percutaneous ...